美国牙髓病医师再生牙髓治疗方案的网络调查
该网络调查向4060名美国牙髓病协会活跃会员发放问卷,850人完成,回复率20.9%。60%的受访者曾实施再生牙髓治疗,方案多参照AAE临床考虑,但整体方案异质性强,未严格遵循AAE建议。
要点
- 60%的受访牙髓病医师曾实施再生牙髓治疗,多数每年1至3例。
- 最常用冲洗液为首次就诊时>3%次氯酸钠和支架形成时EDTA。
- 94.3%使用血凝块作为支架,矿物三氧化物凝聚体为最常用冠方屏障。
核心结论
- 美国牙髓病医师的再生牙髓治疗方案呈现异质性,未严格遵循AAE再生程序临床考虑。
研究设计与样本
- 向4060名美国牙髓病协会活跃会员发放网络问卷,850人完成,回复率20.9%。
主要发现
- 60%的受访者曾实施再生牙髓治疗,多数每年实施1至3例。
- 60.8%的受访者选择AAE再生程序临床考虑作为临床方案来源。
- 92.4%的受访者因时间限制未向AAE.org数据库报告病例,15.5%不知晓该数据库。
- 49.8%的受访者表示会对任何年龄的患者尝试再生牙髓治疗。
关键数值与推荐
- 首次就诊最常用冲洗液为>3%次氯酸钠,支架形成时最常用EDTA。
- 52.2%使用氢氧化钙作为根管内药物,23.5%使用三联抗生素糊剂。
- 77.1%在支架形成时使用不含血管收缩剂的局麻药,94.3%使用血凝块作为支架。
- 矿物三氧化物凝聚体是最常选择的冠方屏障。
- 79.8%的受访者认为有合适病例最能鼓励未来使用再生牙髓治疗,40.1%希望有更好证据。
临床怎么用
- 临床实施再生牙髓治疗时可参照AAE临床考虑,但需注意当前医师方案存在异质性。
- 选择冲洗液、根管内药物和支架材料时应结合AAE建议与可用证据。
局限性
- 调查回复率为20.9%,可能存在无应答偏倚。
- 结果为医师自我报告,可能偏离实际临床操作。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The protocols that endodontists implement for regenerative endodontic procedures (REPs) are unknown. The aim of this study was to examine current REP protocols among practicing endodontists in the United States. METHODS: A Web-based survey was sent to 4060 active members of the American Association of Endodontists (AAE). A total of 850 participants completed the survey, representing a 20.9% response rate. RESULTS: Responses indicated 60% reported having performed REPs; most performed 1 to 3 per year. The most commonly selected source (60.8%) for the clinical protocol was the "AAE Clinical Considerations for a Regenerative Procedure." Time constraints were the most common reason why 92.4% of respondents did not report their REP cases to the AAE.org database; additionally, 15.5% were unaware of it. Almost half (49.8%) of the participants reported they would attempt an REP on a patient of any age. The most commonly used irrigants were >3% sodium hypochlorite at the first appointment and EDTA at the scaffold formation appointment. As the intracanal medicament, 52.2% used calcium hydroxide, whereas 23.5% used triple antibiotic paste. At the scaffold formation appointment, 77.1% used a local anesthetic without a vasoconstrictor, and 94.3% used a blood clot as the scaffold. Mineral trioxide aggregate was the coronal barrier most often selected. Considering factors most likely to encourage the use of REPs in the future, 79.8% reported the availability of good candidates followed by 40.1% who desired better evidence. CONCLUSIONS: Based on the results of this survey, REP protocols appear to be heterogeneous and do not strictly conform to the "AAE Clinical Considerations for a Regenerative Procedure."
引用
- Lee JY, Kersten DD, Mines P, et al. Regenerative Endodontic Procedures among Endodontists: A Web-based Survey. J Endod. 2017. PMID: 29229459. doi:10.1016/j.joen.2017.09.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。